Hepatocellular carcinoma with immature T-cell (T-lymphoblastic) proliferation

Journal of Korean Medical Science

Volumn 25, Issue 2, 2010, Pages 309-312

  Eun, Shin ^a   Jeon, Youn Kyung ^a   Jang, Ja June ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Carcinoma; Hepatocellular; Immunohistochemistry; Indolent T lymphoblastic proliferation; Lymphocytes; Tumor infiltrating

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DNA NUCLEOTIDYLEXOTRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PRE T LYMPHOCYTE; SEGMENTAL MASTECTOMY; TUMOR ASSOCIATED LEUKOCYTE;

ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; CARCINOMA, HEPATOCELLULAR; DNA NUCLEOTIDYLEXOTRANSFERASE; FEMALE; HUMANS; LIVER NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PRECURSOR CELLS, T-LYMPHOID; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951637816     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.2.309     Document Type: Article

References (17)

1. Chiou SH, Sheu BC, Chang WC, Huang SC, Hong-Nerng H. Current concepts of tumor-infiltrating lymphocytes in human malignancies. J Reprod Immunol 2005; 67: 35-50.
2. Liakou CI, Narayanan S, Ng Tang D, Logothetis CJ, Sharma P. Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. Cancer Immunol 2007; 7: 10-5.
3. Ikeguchi M, Oi K, Hirooka Y, Kaibara N. CD8+ lymphocyte infiltration and apoptosis in hepatocellular carcinoma. Eur J Surg Oncol 2004; 30: 53-7.
4. Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007; 132: 2328-39.
5. Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS, Coleman N, Alexander GJ. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41: 722-30.
6. Chen CJ, Jeng LB, Huang SF. Lymphoepithelioma-like hepatocellular carcinoma. Chang Gung Med J 2007; 30: 172-7.
7. Emile JF, Adam R, Sebagh M, Marchadier E, Falissard B, Dussaix E, Bismuth H, Reynés M. Hepatocellular carcinoma with lymphoid stroma: a tumour with good prognosis after liver transplantation. Histopathology 2000; 37: 523-9.
8. Chen CH, Lee HS, Huang GT, Yang PM, Yu WY, Cheng KC, Lee PH, Jeng YM, Chen DS, Sheu JC. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma. Hepatogastroenterology 2007; 54: 1529-33.
9. Pescovitz MD. Sakopoulos AG, Gaddy JA, Husmann RJ, Zuckermann FA. Porcine peripheral blood CD4+/CD8+ dual expressing T-cells. Vet Immunol Immunopathol 1994; 43: 53-62.
10. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005; 33: 52-62.
11. Sato K, Ohtsuka K, Hasegawa K, Yamagiwa S, Watanabe H, Asakura H, Abo T. Evidence for extrathymic generation of intermediate T cell receptor cells in the liver revealed in thymectomized, irradiated mice subjected to bone marrow transplantation. J Exp Med 1995; 182: 759-67.
12. Ohteki T, Seki S, Abo T, Kumagai K. Liver is a possible site for the proliferation of abnormal CD3+4-8-double-negative lymphocytes in autoimmune MRL-lpr/lpr mice. J Exp Med 1990; 172: 7-12.
13. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174: 5-20.
14. Miyaji C, Watanabe H, Osman Y, Kuwano Y, Abo T. A comparison of proliferative response to IL-7 and expression of IL-7 receptors in intermediate TCR cells of the liver, spleen, and thymus. Cell Immunol 1996; 169: 159-65.
15. Wang ZM, Xiao WB, Zheng SS, Sun K, Wang LJ. Hepatocellular carcinoma with Indolent T-lymphoblastic proliferation. Leuk Lymphoma 2006; 47: 2424-6.
16. Velankar MM, Nathwani BN, Schlutz MJ, Bain LA, Arber DA, Slovak ML, Weiss LM. Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol 1999; 23: 977-81.
17. Strauchen JA. Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis. Am J Surg Pathol 2001; 25: 411-5.